WuXi Biologics Receives ESG Corporate Platinum Award from The Asset for Fourth Consecutive Year
HONG KONG,Oct. 16,2024-- WuXi Biologics ("WuXi Bio") (2269.HK),a leading global Contract Research,Development and Manufacturing Organization (CRDMO),today announced that it has received a Pl